Form D · Biotechnology
COGNITION THERAPEUTICS INC
Pittsburgh, PA · CIK 0001455365
Offering snapshot reported Nov 28, 2018 · SEC filing
- Reported sold
- $1.65M Offering amount: $8M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 28, 2018 | Initial | $1,646,868 | No comparison | 28 | SEC filing |
| Mar 15, 2018 | Initial | $2,409,575 | No comparison | 31 | SEC filing |
| Jan 18, 2017 | Amendment | $4,176,324 | $1,176,419vs Nov 30, 2016 | 50 | SEC filing |
| Nov 30, 2016 | Initial | $2,999,905 | No comparison | 45 | SEC filing |
| Mar 31, 2016 | Initial | $3,470,072 | No comparison | 41 | SEC filing |
| Jul 22, 2015 | Amendment | $15,834,018 | $6,646,384vs Apr 10, 2015 | 56 | SEC filing |
| Apr 10, 2015 | Amendment | $9,187,634 | $3,203,177vs Apr 1, 2014 | 48 | SEC filing |
| Apr 1, 2014 | Initial | $5,984,457 | No comparison | 31 | SEC filing |
| Sep 5, 2013 | Amendment | $3,023,735 | $1,101,986vs Jan 3, 2013 | 25 | SEC filing |
| Jan 3, 2013 | Initial | $1,921,749 | No comparison | 17 | SEC filing |
| Dec 6, 2011 | Initial | $1,823,845 | No comparison | 16 | SEC filing |
| Dec 28, 2010 | Initial | $2,500,000 | No comparison | 22 | SEC filing |
| Jan 29, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-326673
Source: Form D, filed Nov 28, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Breedlove | Director |
| Susan Catalano | Director, Executive |
| Aaron Fletcher | Director |
| Robert Gailus | Director |
| Franz Hefti | Director |
| Nada Jain | Director |
| Kenneth I. Moch | Director, Executive |
| Harold Safferstein | Director, Executive |
| Stephen Sands | Director |
| Irwin Scher | Director |
| Peggy Wallace | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2403 Sidney Street Suite 261
Pittsburgh, PA, 15203
Pittsburgh, PA, 15203